Free Trial
→ Elon Musk’s One Stock Retirement Plan (From Brownstone Research) (Ad)tc pixel Free TVTX Stock Alerts

Travere Therapeutics (TVTX) Short Interest Ratio & Short Volume

Travere Therapeutics logo
$52.94 +1.14 (+2.19%)
As of 12:46 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Travere Therapeutics Short Interest Overview

As of September 30, 2026, Travere Therapeutics (TVTX) had a short interest of 12.66 million shares sold short, representing 14.05% of the public float. This marks a -2.32% decrease in short interest since the prior report. The short interest ratio (days to cover) is 7.2, meaning it would take 7.2 days of the average trading volume of 2.00 million shares to cover all short positions.

Current Short Interest
12,655,839 shares
Previous Short Interest
12,955,933 shares
Change Vs. Previous Month
-2.32%
Dollar Volume Sold Short
$745.18 million
Short Interest Ratio
7.2 Days to Cover
Last Record Date
September 30, 2026
Outstanding Shares
94,260,000 shares
Short Percent of Float
14.05%
Today's Trading Volume
636,170 shares
Average Trading Volume
1,995,982 shares
Today's Volume Vs. Average
32%
Short Selling Travere Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Travere Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TVTX Short Interest Over Time

TVTX Days to Cover Over Time

TVTX Percentage of Float Shorted Over Time

Travere Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202612,655,839 shares $745.18 million -2.3%14.1%7.23 $58.88
9/15/202612,955,933 shares $809.88 million +7.9%14.4%10.38 $62.51
8/31/202612,004,820 shares $795.68 million +0.5%13.3%9.56 $66.28
8/14/202611,943,638 shares $742.18 million +2.3%13.3%5.7 $62.14
7/31/202611,676,586 shares $652.60 million -2.8%13.0%9.41 $55.89
7/15/202612,015,392 shares $681.75 million -5.3%13.5%9.15 $56.74
6/30/202612,687,615 shares $720.78 million -5.6%14.3%4.71 $56.81
6/15/202613,437,418 shares $722.93 million -4.9%15.1%6.39 $53.80
5/29/202614,122,154 shares $666.28 million +0.8%15.9%8.16 $47.18
5/15/202614,008,379 shares $596.62 million -1.5%15.8%4.48 $42.59
4/30/202614,216,705 shares $598.81 million +11.7%16.0%7.2 $42.12
4/15/202612,725,544 shares $521.11 million -5.4%14.3%3.73 $40.95
3/31/202613,446,405 shares $399.39 million +0.5%15.1%11.01 $29.70
3/13/202613,383,909 shares $372.07 million -5.6%15.1%10.64 $27.80
2/27/202614,180,739 shares $422.44 million -6.8%16.0%9.69 $29.79
2/13/202615,217,326 shares $423.35 million +5.0%17.1%10.77 $27.82
1/30/202614,491,659 shares $450.55 million -5.7%16.3%8.67 $31.09
1/15/202615,365,503 shares $436.38 million +7.4%17.3%3.45 $28.40
12/31/202514,312,827 shares $546.89 million +17.4%16.1%7.31 $38.21
12/15/202512,196,281 shares $423.94 million +11.2%13.7%8.06 $34.76
11/28/202510,969,722 shares $390.25 million +5.9%12.3%8.35 $35.58
11/14/202510,355,808 shares $357.28 million -4.8%12.1%4.81 $34.50
10/31/202510,879,506 shares $382.52 million -8.1%12.7%4.98 $35.16
10/15/202511,840,000 shares $317.90 million +5.3%13.8%5.8 $26.85
9/30/202511,240,000 shares $268.64 million -8.8%N/A5.7 $23.90
9/15/202512,320,000 shares $283.48 million +2.0%N/A6.4 $23.01
8/31/202512,080,000 shares $211.40 million -0.3%14.1%6.7 $17.50
8/15/202512,110,000 shares $227.91 million +14.0%N/A8.1 $18.82
7/31/202510,620,000 shares $164.08 million -17.4%12.4%6.8 $15.45
7/15/202512,860,000 shares $210.65 million +857,233.3%N/A7.9 $16.38
6/30/20251,500 shares $22.20 thousand -100.0%0.0%0 $14.80
6/15/202510,330,000 shares $149.79 million -17.4%12.1%5.9 $14.50
5/31/202512,500,000 shares $187.25 million +19.9%16.6%7.1 $14.98
5/15/202510,430,000 shares $220.59 million -2.0%13.9%5.8 $21.15
4/30/202510,640,000 shares $221.42 million -3.7%N/A5.7 $20.81
4/15/202511,050,000 shares $164.76 million -4.4%14.7%6.2 $14.91
3/31/202511,560,000 shares $207.16 million +3.3%15.4%6.6 $17.92
3/15/202511,190,000 shares $220.78 million +2.2%14.9%7 $19.73
2/28/202510,950,000 shares $234.33 million -3.1%14.6%7.2 $21.40
2/15/202511,300,000 shares $258.88 million +18.2%15.0%7.7 $22.91
How one AI fund pays investors every Thursday (Ad)

One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling shares or trading options, but simply by holding the fund and letting it pay out cash every Thursday. That works out to a 34% annualized distribution rate, even though the underlying AI stocks pay no dividends themselves. Tim Plaehn, Chief Income Strategist at Investors Alley, breaks down exactly how the fund generates these weekly payouts.tc pixel

Watch the free presentation to see how the payouts work
1/31/20259,560,000 shares $195.60 million -0.2%N/A6.8 $20.46
1/15/20259,580,000 shares $173.11 million +9.9%N/A7.4 $18.07
12/31/20248,720,000 shares $151.90 million +17.7%N/A5.9 $17.42
12/15/20247,410,000 shares $128.34 million -2.1%N/A4.5 $17.32
11/30/20247,570,000 shares $142.39 million +8.6%N/A4.3 $18.81
11/15/20246,970,000 shares $123.51 million -12.8%N/A3.6 $17.72
10/31/20247,990,000 shares $139.83 million -1.5%N/A4.4 $17.50
10/15/20248,110,000 shares $143.47 million +16.5%N/A4.7 $17.69
9/30/20246,960,000 shares $97.37 million -19.6%N/A4.2 $13.99
9/15/20248,660,000 shares $116.74 million -6.4%N/A6.2 $13.48
8/31/20249,250,000 shares $87.60 million -0.5%N/A7.2 $9.47
8/15/20249,300,000 shares $81.65 million -7.8%N/A8.5 $8.78
7/31/202410,090,000 shares $96.26 million -0.1%N/A8.8 $9.54
7/15/202410,100,000 shares $99.08 million -2.1%N/A8.2 $9.81
6/30/202410,320,000 shares $84.83 million -23.1%N/A8.2 $8.22
6/15/202413,414,700 shares $96.18 million -0.4%N/A11 $7.17
5/31/202413,470,000 shares $99.95 million +0.2%N/A11.3 $7.42
5/15/202413,440,000 shares $91.39 million +4.9%N/A11 $6.80
4/30/202412,810,000 shares $70.84 million +8.6%N/A10.3 $5.53
4/15/202411,800,000 shares $74.58 million +11.3%N/A9.9 $6.32
3/31/202410,600,000 shares $81.73 million +5.3%N/A8.8 $7.71
3/15/202410,070,000 shares $75.42 million -1.9%N/A8.2 $7.49
2/29/202410,260,000 shares $77.57 million +5.1%N/A7.5 $7.56
2/15/20249,760,000 shares $85.30 million -1.7%N/A6.7 $8.74
1/31/20249,930,000 shares $88.67 million +2.3%N/A6.3 $8.93
1/15/20249,710,000 shares $92.54 million -2.1%N/A5.8 $9.53
12/31/20239,920,000 shares $89.18 million +2.9%N/A5.9 $8.99
12/15/20239,640,000 shares $83.48 million -3.1%N/A5.8 $8.66
11/30/20239,950,000 shares $62.49 million -6.7%N/A5 $6.28
11/15/202310,660,000 shares $65.77 million +21.0%N/A5.9 $6.17
10/31/20238,810,000 shares $57.09 million +0.5%N/A5.2 $6.48
10/15/20238,770,000 shares $62.27 million +4.2%N/A5.6 $7.10
9/30/20238,420,000 shares $75.27 million -6.9%N/A5.8 $8.94
9/15/20239,040,000 shares $123.76 million +5.7%N/A6.7 $13.69
8/31/20238,550,000 shares $122.09 million +5.6%N/A8.3 $14.28
8/15/20238,100,000 shares $123.12 million +0.4%N/A7.6 $15.20
7/31/20238,070,000 shares $138.72 million -2.7%N/A7.3 $17.19
7/15/20238,290,000 shares $126.92 million -2.5%N/A6.5 $15.31
6/30/20238,500,000 shares $130.56 million +11.0%N/A6.3 $15.36
6/15/20237,660,000 shares $131.75 million +4.9%N/A5.4 $17.20
5/31/20237,300,000 shares $130.60 million -3.2%N/A5.4 $17.89
5/15/20237,540,000 shares $123.20 million -4.1%N/A4.7 $16.34
4/30/20237,860,000 shares $169.54 million -3.7%N/A4.7 $21.57
4/15/20238,160,000 shares $165.81 million -4.5%N/A5.6 $20.32
3/31/20238,540,000 shares $192.06 million +14.8%N/A5.7 $22.49
3/15/20237,440,000 shares $158.25 million -1.6%N/A5.4 $21.27
2/28/20237,560,000 shares $167.53 million +9.9%N/A5.7 $22.16
2/15/20236,880,000 shares $138.43 million -7.7%N/A5.8 $20.12
1/31/20237,450,000 shares $166.88 million -0.9%N/A8.8 $22.40
1/15/20237,520,000 shares $152.81 million -10.3%N/A9.1 $20.32
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad)

Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.tc pixel

Watch the video to learn how this plan could affect you
12/30/20228,380,000 shares $176.23 million +3.1%N/A10 $21.03
12/15/20228,130,000 shares $150.41 million -1.2%N/A9.7 $18.50
11/30/20228,230,000 shares $165.67 million +5.9%N/A10.6 $20.13
11/15/20227,770,000 shares $167.13 million -1.2%N/A10.4 $21.51
10/31/20227,860,000 shares $170.40 million +23.0%13.0%10.9 $21.68
10/15/20226,390,000 shares $132.15 million -6.2%10.6%8.4 $20.68
9/30/20226,810,000 shares $167.80 million +3.0%11.3%10.3 $24.64
9/15/20226,610,000 shares $179.79 million -0.5%11.0%9.9 $27.20
8/31/20226,640,000 shares $177.69 million -10.2%11.1%9 $26.76
8/15/20227,390,000 shares $211.28 million +7.9%12.3%9.7 $28.59
7/31/20226,850,000 shares $161.25 million +2.4%11.5%7.9 $23.54
7/15/20226,690,000 shares $163.97 million -5.0%11.2%8.4 $24.51
6/30/20227,040,000 shares $170.58 million +6.2%11.8%8.6 $24.23
6/15/20226,630,000 shares $160.18 million -10.4%11.1%8 $24.16
5/31/20227,400,000 shares $172.49 million -12.6%12.4%8.9 $23.31
5/15/20228,470,000 shares $187.86 million +3.7%14.2%9.7 $22.18
4/30/20228,170,000 shares $205.31 million +14.1%13.8%10.5 $25.13
4/15/20227,160,000 shares $212.22 million +0.7%12.1%9.3 $29.64
3/31/20227,110,000 shares $183.22 million -6.5%12.0%9.8 $25.77
3/15/20227,600,000 shares $181.72 million +29.3%12.8%11.5 $23.91
2/28/20225,880,000 shares $160.29 million -1.7%10.0%9.1 $27.26
2/15/20225,980,000 shares $171.39 million +11.4%10.5%11 $28.66
1/31/20225,370,000 shares $147.68 million +8.5%9.3%10.6 $27.50
1/15/20224,950,000 shares $136.32 million -15.5%8.5%9.3 $27.54
12/31/20215,860,000 shares $181.89 million -6.4%N/A0 $31.04
12/15/20216,260,000 shares $182.48 million +0.6%10.8%11.6 $29.15
11/30/20216,220,000 shares $177.58 million +3.0%10.7%10.5 $28.55
11/15/20216,040,000 shares $177.39 million -1.2%10.4%9.7 $29.37
10/29/20216,110,000 shares $176.03 million +0.5%10.1%5 $28.81
10/15/20216,080,000 shares $148.96 million -6.9%10.2%5.1 $24.50

TVTX Short Interest - Frequently Asked Questions

Short interest is the volume of Travere Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 12,655,839 shares of TVTX short. 14.05% of Travere Therapeutics' shares are currently sold short. Learn More on Travere Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TVTX shares currently have a short interest ratio of 7.2. Learn More on Travere Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.05% of Travere Therapeutics' floating shares are currently sold short.

Travere Therapeutics saw a decrease in short interest in the month of September. As of September 30th, there was short interest totaling 12,655,839 shares, a decrease of 2.3% from the previous total of 12,955,933 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

14.05% of Travere Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Travere Therapeutics: Exelixis, Inc. (11.68%), Ascendis Pharma A/S (9.31%), Summit Therapeutics PLC (31.27%), BridgeBio Pharma, Inc. (11.73%), Halozyme Therapeutics, Inc. (13.82%), Madrigal Pharmaceuticals, Inc. (12.59%), BioMarin Pharmaceutical Inc. (5.99%), ImmunityBio, Inc. (34.54%), Vaxcyte, Inc. (12.02%), Krystal Biotech, Inc. (13.51%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks.

Short selling TVTX is an investing strategy that aims to generate trading profit from Travere Therapeutics as its price is falling. TVTX shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Travere Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TVTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TVTX, twice per month. The most recent reporting period available is September, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TVTX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:TVTX is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Elon's next millionaires start October 24?
SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...
Behind the Markets | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
How one AI fund pays investors every Thursday
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel
Rent out your stocks?
If you owned a rental house, you would collect rent while you waited for it to rise in value. A covered call l...
Profits Run | Sponsoredtc pixel
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...
Paradigm Press | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel